Browsing by Author Rawling, T

0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Showing results 1 to 20 of 29  next >
Issue DateTitleAuthor(s)
1-Jun-2018Activity of novel lipid glycine transporter inhibitors on synaptic signalling in the dorsal horn of the spinal cordWinters, BL; Rawling, T; Vandenberg, RJ; Christie, MJ; Bhola, RF; Imlach, WL
6-Nov-2016Alkaloid-like Molecules for Drug DiscoveryWilliams, SG; Rawling, T; Ung, AT
1-Jan-2013Anti-proliferative actions of N0-desmethylsorafenib in human breast cancer cellsCui, PH; Rawling, T; Gillani, TB; Bourget, K; Wang, XS; Zhou, F; Murray, M
1-Jun-2015Anti-tumor activities of lipids and lipid analogues and their development as potential anticancer drugsMurray, M; Hraiki, A; Bebawy, M; Pazderka, C; Rawling, T
1-Jan-2017Antiproliferative activities of alkaloid-like compoundsXu, X; Rawling, T; Roseblade, A; Bishop, R; Ung, AT
23-May-2018Carboxylate Analogues of Aryl-Urea-Substituted Fatty Acids That Target the Mitochondria in MDA-MB-231 Breast Cancer Cells to Promote Cell DeathKoolaji, N; Rawling, T; Bourget, K; Murray, M
17-Dec-2013Cell-derived microparticles: New targets in the therapeutic management of diseaseRoseblade, A; Luk, F; Rawling, T; Ung, A; Grau, GER; Bebawy, M
8-Jul-2008Convenient synthesis and purification of [Bu<inf>4</inf>N] <inf>2</inf>[Ru(4-carboxy-4-carboxylate-2,2′-bipyridine) <inf>2</inf>(NCS)<inf>2</inf>]: A landmark DSC DyeRawling, T; Buchholz, F; McDonagh, AM
1-Mar-2018Differential effects of hepatic cirrhosis on the intrinsic clearances of sorafenib and imatinib by CYPs in human liverMurray, M; Gillani, TB; Ghassabian, S; Edwards, RJ; Rawling, T
1-Feb-2010Facile and stereoselective synthesis of (Z)-15-octadecenoic acid and (Z)-16-nonadecenoic acid: Monounsaturated omega-3 fatty acidsRawling, T; Duke, CC; Cui, PH; Murray, M
1-May-2011Factors affecting internal standard selection for quantitative elemental bio-imaging of soft tissues by LA-ICP-MSAustin, C; Fryer, F; Lear, J; Bishop, D; Hare, D; Rawling, T; Kirkup, L; McDonagh, A; Doble, P
13-Oct-2018Nanoemulsion-enabled oral delivery of novel anticancer ω-3 fatty acid derivativesPereira, GG; Rawling, T; Pozzoli, M; Pazderka, C; Chen, Y; Dunstan, CR; Murray, M; Sonvico, F
26-Oct-2017A Novel Arylurea Fatty Acid That Targets the Mitochondrion and Depletes Cardiolipin to Promote Killing of Breast Cancer CellsRawling, T; Choucair, H; Koolaji, N; Bourget, K; Allison, SE; Chen, YJ; Dunstan, CR; Murray, M
1-Jan-2017A novel synthetic analogue of v-3 17,18-epoxyeicosatetraenoic acid activates TNF receptor-1/ ASK1/JNK signaling to promote apoptosis in human breast cancer cellsDyari, HRE; Rawling, T; Chen, Y; Sudarmana, W; Bourget, K; Dwyer, JM; Allison, SE; Murray, M
2-Apr-2007Optical and redox properties of ruthenium phthalocyanine complexes tuned with axial ligand substituentsRawling, T; Xiao, H; Lee, ST; Colbran, SB; McDonagh, AM
1-Jan-2010Perylene dye photodegradation due to ketones and singlet oxygenEarp, AA; Rawling, T; Franklin, JB; Smith, GB
10-May-2010Quantification method for elemental bio-imaging by LA-ICP-MS using metal spiked PMMA filmsAustin, C; Hare, D; Rawling, T; McDonagh, AM; Doble, P
15-Jul-2012Role of human CYP3A4 in the biotransformation of sorafenib to its major oxidized metabolitesGhassabian, S; Rawling, T; Zhou, F; Doddareddy, MR; Tattam, BN; Hibbs, DE; Edwards, RJ; Cui, PH; Murray, M
1-May-2007Ruthenium phthalocyanine and naphthalocyanine complexes: Synthesis, properties and applicationsRawling, T; McDonagh, A
2008Ruthenium phthalocyanine complexes : synethsis, properties and applicationsRawling, T